AMG-458
CAS No. 913376-83-7
AMG-458 ( AMG458 | AMG 458 )
产品货号. M16561 CAS No. 913376-83-7
AMG-458 (AMG458) 是一种有效的、选择性的、口服生物可利用的 c-Met 抑制剂,Ki 为 1.2 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥794 | 有现货 |
|
| 5MG | ¥1393 | 有现货 |
|
| 10MG | ¥2066 | 有现货 |
|
| 25MG | ¥3953 | 有现货 |
|
| 50MG | ¥5767 | 有现货 |
|
| 100MG | ¥7995 | 有现货 |
|
| 500MG | ¥16038 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称AMG-458
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述AMG-458 (AMG458) 是一种有效的、选择性的、口服生物可利用的 c-Met 抑制剂,Ki 为 1.2 nM。
-
产品描述AMG-458 (AMG458) is a potent, selective, orally bioavailable c-Met inhibitor with Ki of 1.2 nM (human c-Met); also potently binds to mutant c-Met (H1094R), c-Met (V1092I) and c-Met (D1228H) with Ki values of 0.5-2.2 nM; inhibits HGF-mediated c-Met phosphorylation in PC3 and CT26 cells with IC50 of 60 and 120 nM, abrogates the constitutive phosphorylation of c-Met in H441 cells; significantly inhibits tumor growth in the NIH3T3/TPR-Met and U-87 MG xenograft models.
-
体外实验——
-
体内实验AMG-458 (orally, 30, 100 mg/kg) significantly inhibits tumor growth in the NIH3T3/TPR-Met and U-87 MG xenograft models with no adverse effect on body weight. Animal Model:NIH-3T3/TPR-Met model and U-87 MG human glioblastoma xenograft model.Dosage:10, 30, 100 mg/kg.Administration:Orally q.d. or b.i.d.Result:With an ED50 of ~12 mg/kg and an ED90 of ~ 34 mg/kg in NIH-3T3/TPR-Met model.With an ED50 of ~16 mg/kg and an ED90 of ~ 59 mg/kg in U-87 MG human glioblastoma xenograft model.Significantly inhibited tumor growth at 30 and 100 mg/kg q.d. and 30 mg/kg b.i.d. without adverse effect on body weight.Animal Model:Balb/c mouse and SD rat.Dosage:1 mg/kg (Pharmacokinetic Analysis).Administration:IV dose: 1 mg/kg (20% Captisol with pH adjusted to 3.5 using methanesulfonic acid). Result:Exhibited CL ((L/h)/kg) values of 0.16 and 0.73, Vss (L/kg) values of 0.31 and 0.62, t1/2 (h) values of 1.3 and 1.0 in mouse and rat, respectively.
-
同义词AMG458 | AMG 458
-
通路Angiogenesis
-
靶点c-Met/HGFR
-
受体c-Met(D1228H)|c-Met(H1094R)|c-Met(Human)|c-Met(Mouse)|c-Met(V1092I)
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number913376-83-7
-
分子量539.592
-
分子式C30H29N5O5
-
纯度>98% (HPLC)
-
溶解度DMSO: 21 mg/mL (38.91 mM); Ethanol: <1 mg/mL; Water: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(C1=C(C)N(CC(C)(O)C)N(C2=CC=CC=C2)C1=O)NC3=NC=C(OC4=CC=NC5=CC(OC)=CC=C45)C=C3
-
化学全称1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Liu L, et al. J Med Chem. 2008 Jul 10;51(13):3688-91.
2. Tiedt R, et al. Cancer Res. 2011 Aug 1;71(15):5255-64.
3. van den Heuvel CNAM, et al. Mol Cancer Res. 2017 Nov;15(11):1587-1597.
产品手册
关联产品
-
Norcantharidin b
去甲斑蝥素是一种合成抗癌化合物,是人类结肠癌中 c-Met 和 EGFR 的双重抑制剂。
-
Amivantamab
Amivantamab (JNJ-61186372)?是一种人源 EGFR-MET 双特异性抗体,具有免疫抗癌活性。Amivantamab 可以抑制配体结合,促进受体-抗体复合物的内吞作用和降解,并诱导巨噬细胞的 Fc 依赖性胞吞作用和自然杀伤细胞的抗体依赖性细胞毒性。
-
MET inhibitor Compou...
一种新型有效、选择性口服生物可利用的 MET 酪氨酸激酶抑制剂,对于未磷酸化和磷酸化 MET 的 IC50 值分别 <1 nM 和 12 nM。
021-51111890
购物车()
sales@molnova.cn

